Mannosylated liposomes to improve mRNA based vaccination

SATT LUTECH



13 Septembre 2018

Partager sur facebook Partager sur twitter Partager sur linkedin Partager sur google+

Fields

Biology / Medical

Sectors

Health
The present invention is based on an optimized liposomal formulation to improve targeting and maturation of dendritic cells enabling and consequently the efficacy of mRNA vaccines
Download the offer Download the offer

Newsletter